These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34011083)

  • 41. ALK Immunoexpression is Specific for Inflammatory Myofibroblastic Tumor Among Vulvovaginal Mesenchymal Neoplasms.
    Bowman CJ; Medeiros F; Fadare O; Sangoi AR; Horvai AE; Devine WP; McCluggage WG; Rabban JT
    Int J Gynecol Pathol; 2023 Jan; 42(1):1-10. PubMed ID: 35180768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inflammatory myofibroblastic tumors of the lung carrying a chimeric A2M-ALK gene: report of 2 infantile cases and review of the differential diagnosis of infantile pulmonary lesions.
    Tanaka M; Kohashi K; Kushitani K; Yoshida M; Kurihara S; Kawashima M; Ueda Y; Souzaki R; Kinoshita Y; Oda Y; Takeshima Y; Hiyama E; Taguchi T; Tanaka Y
    Hum Pathol; 2017 Aug; 66():177-182. PubMed ID: 28705706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A recurrent inflammatory myofibroblastic tumor patient with two novel
    Xu X; Li L; Zhang Y; Meng F; Xie H; Duan R
    Transl Cancer Res; 2022 Sep; 11(9):3379-3384. PubMed ID: 36237256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.
    Chmiel P; SłOWIKOWSKA A; Banaszek Ł; Szumera-CIEćKIEWICZ A; Szostakowski B; SPAłEK MJ; Świtaj T; Rutkowski P; Czarnecka AM
    Oncol Res; 2024; 32(7):1141-1162. PubMed ID: 38948020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid Response to Lorlatinib in a Patient With TFG-ROS1 Fusion Positive Inflammatory Myofibroblastic Tumor of the Chest Wall Metastatic to the Brain and Refractory to First and Second Generation ROS1 Inhibitors.
    Carcamo B; Bista R; Wilson H; Reddy P; Pacheco J
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e718-e722. PubMed ID: 34157012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation.
    Ogata M; Hatachi Y; Ogata T; Satake H; Imai Y; Yasui H
    Intern Med; 2019 Apr; 58(7):1029-1032. PubMed ID: 30449794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
    Alan O; Kuzhan O; Koca S; Telli TA; Basoglu T; Ercelep O; Filinte D; Sengul Y; Arikan H; Kaya S; Babacan NA; Dane F; Yumuk PF
    J Oncol Pharm Pract; 2020 Jun; 26(4):1011-1018. PubMed ID: 31615346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An isolated inflammatory myofibroblastic tumor of adrenal gland.
    Al Sannaa G; Wimmer JL; Ayala AG; Ro JY
    Ann Diagn Pathol; 2016 Dec; 25():33-36. PubMed ID: 27806843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report.
    Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW
    Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two cases of inflammatory myofibroblastic tumor treated with targeted drugs: A case report.
    Liu M; Zhu D
    Medicine (Baltimore); 2024 May; 103(21):e38136. PubMed ID: 38787978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study.
    Gambacorti-Passerini C; Orlov S; Zhang L; Braiteh F; Huang H; Esaki T; Horibe K; Ahn JS; Beck JT; Edenfield WJ; Shi Y; Taylor M; Tamura K; Van Tine BA; Wu SJ; Paolini J; Selaru P; Kim TM
    Am J Hematol; 2018 May; 93(5):607-614. PubMed ID: 29352732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rare presentation of inflammatory myofibroblastic tumor on a digit.
    West CE; Workman A; Moody T; Hosler GA
    J Cutan Pathol; 2021 Jul; 48(7):965-968. PubMed ID: 33754372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor.
    Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H
    Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion.
    Furugaki K; Mochizuki M; Kohno M; Shu S; Harada N; Yoshimura Y
    BMC Cancer; 2019 Apr; 19(1):301. PubMed ID: 30943926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement: a report of two cases and literature review.
    Li J; Yin WH; Takeuchi K; Guan H; Huang YH; Chan JK
    Diagn Pathol; 2013 Sep; 8():147. PubMed ID: 24034896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer.
    Ginestet F; Lambros L; Le Flahec G; Marcorelles P; Uguen A
    Clin Lung Cancer; 2018 Sep; 19(5):e647-e653. PubMed ID: 29801706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastric and cardiac inflammatory myofibroblastic tumor: an extremely rare case.
    Huang Y; Zhang M; Li Q; Huang Q
    J Cardiothorac Surg; 2024 Jan; 19(1):31. PubMed ID: 38287440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mixed responses to first-line alectinib in non-small cell lung cancer patients with rare ALK gene fusions: A case series and literature review.
    Li M; An Z; Tang Q; Ma Y; Yan J; Chen S; Wang Y
    J Cell Mol Med; 2021 Oct; 25(19):9476-9481. PubMed ID: 34541785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Core Biopsy Diagnosis of ALK Positive Inflammatory Myofibroblastic Tumor of Lung: An Interesting Case.
    Sachdev R; Mohapatra I; Goel S; Ahlawat K; Sharma N
    Turk Patoloji Derg; 2020; 36(2):173-177. PubMed ID: 30632123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leiomyoma-like Morphology in Metastatic Uterine Inflammatory Myofibroblastic Tumors.
    Devins KM; Samore W; Nielsen GP; Deshpande V; Oliva E
    Mod Pathol; 2023 Jun; 36(6):100143. PubMed ID: 36806735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.